Download The IgAN Handbook
Learn more about IgA Nephropathy by downloading our easy-to-access handbook! Fill out the form below and get access to the handbook!
The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.
Learn more about IgA Nephropathy by downloading our easy-to-access handbook! Fill out the form below and get access to the handbook!